Chemoprevention of bladder cancer

Urologic Clinics of North America

Volumn 29, Issue 1, 2002, Pages 157-168

  Kamat, Ashish M ^a   Lamm, Donald L ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENE; CIPROFLOXACIN; GARLIC EXTRACT; LYCOPENE; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; OLTIPRAZ; ORNITHINE DECARBOXYLASE INHIBITOR; PIROXICAM; PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOID; RETINOL; SELENIUM; SOYBEAN PROTEIN;

BLADDER CANCER; CHEMOPROPHYLAXIS; CYTOTOXICITY; DIET SUPPLEMENTATION; DRUG MEGADOSE; FAT INTAKE; FLUID INTAKE; FOOD INTAKE; HUMAN; LIFESTYLE; LIVER TOXICITY; NUTRITION; PRIORITY JOURNAL; PROSTATE CANCER; RETINOL INTOXICATION; REVIEW; STATISTICAL ANALYSIS; TEA; URINE PH; VEGETABLE; VITAMIN SUPPLEMENTATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA, TRANSITIONAL CELL; CAROTENOIDS; CHEMOPREVENTION; HUMANS; HYDROGEN-ION CONCENTRATION; URINARY BLADDER NEOPLASMS; URINE; VITAMINS;

EID: 0036304007     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00022-8     Document Type: Review

References (75)

1. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors: A double-blind clinical trial
2. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat
3. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine
4. Single nutrient effects on immunologic functions: Report of a workshop sponsored by the Department of Food and Nutrition and its nutrition advisory group of the American Medical Association
5. Tea consumption and risk of bladder and kidney cancers in a population-based case-control study
6. Update on the effects of vitamins A, C, and E and selenium on carcinogenesis
7. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review
8. The metabolism of tryptophan in patients with bladder cancer
9. Beta-carotene: An unusual type of lipid antioxidant
10. Green tea and cancer in humans: A review of the literature
11. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer
12. Epidemiologic evidence for vitamin C and vitamin E in cancer prevention
13. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells
14. Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint
15. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-Year follow-up of the prospective Basel study
16. Konservative behandlung der rezidivierenden harnblasenpapillomatose mit vitamin-a-saure. Vorlafige mitteilung
17. Cancer of the prostate: A nutritional disease?
18. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats
19. Absence of promotion potential for calcium L-ascorbate, Lascorbic dipalmitate, L-ascorbic stearate and erythorbic acid on rat urinary bladder carcinogenesis
20. High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer
21. Suppression of tumor growth and enhancement of immune status with high levels of dietary vitamin B6 in BALB/c mice
22. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer
23. The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents
24. Validity of short-term examination for antipromoters of bladder carcinogenesis
25. Quinolone antibiotics: A potential adjunct to intravesical chemotherapy for bladder cancer
26. Inhibitory effects of ascorbic acid on growth of leukemic and lymphoma cell lines
27. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder
28. Megadose vitamins in bladder cancer: A double-blind clinical trial
29. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder
30. Superiority of intralesional immunotherapy with Corynebacterium parvum and Allium sativum in the control of murine transitional cell carcinoma
31. Effect of urinary pH on the progression of urinary bladder tumours
32. Toxicity evaluation of difluoromethylornithine: Doses for chemoprevention trials
33. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
34. Prognostic parameters in superficial bladder cancer: An analysis of 315 cases
35. Effects of carotenoid administration on bladder cancer prevention
36. Normal and malignant human urothelium: In vitro response to blockade of polyamine synthesis and interconversion
37. Dietary risk factors in human bladder cancer
38. Fluid intake and the risk of bladder cancer in men
39. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer
40. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC
41. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats
42. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO
43. Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse
44. Bladder cancer incidence in relation to vegetable and fruit consumption: A prospective study of atomic bomb survivors
45. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer: Results of a prospective, randomized phase III study performed by the EORTC GU Group
46. Dietary factors in cancer of the lower urinary tract
47. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment
48. Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine nitiation
49. The role of epidemiology in cancer prevention
50. Chemoimmunoprophylaxis of an experimental bladder cancer with retinoids and bacillus Calmette-Guérin
51. Vitamin C intake influences the bleomycin-induced chromosome damage assay: Implications for detection of cancer susceptibility and chromosome breakage syndromes
52. 13-cis-retinoic acid in chemoprevention of superficial bladder cancer
53. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder
54. The importance of selenium to human health
55. Human tumour-induced inhibition of interferon action in vitro: Reversal by beta-carotene (pro-vitamin A)
56. Allium sativum (garlic) treatment for murine transitional cell carcinoma
57. Dietary factors and the incidence of cancer of the urinary bladder
58. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers
59. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine
60. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea
61. Proposed uses of ascorbic acid in the prevention of bladder carcinoma
62. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: A prospective study
63. Molecular genetics and biochemical mechanisms in bladder cancer
64. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells
65. Chemoprevention of cancer with retinoids
66. Vitamin A supplements, fried foods, fat and urothelial cancer: A case-referent study in Stockholm in 1985-87
67. Diet and bladder cancer: A meta-analysis of six dietary variables
68. Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors: Final analysis of a prospective, randomized multicenter trial in Switzerland
69. Pyridoxine supplementation: Effect on lymphocyte responses in elderly perons
70. Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial
71. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells
72. Prevention, therapy and basic science and the resolution of the cancer problem
73. What are the critical attributes for cancer preventive agents?
74. Prophylactic effect of etretinate on the recurrence of superficial bladder tumors - Results of a randomized control study
75. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis